Nora Jaskowiak to Follow-Up Studies
This is a "connection" page, showing publications Nora Jaskowiak has written about Follow-Up Studies.
Connection Strength
0.144
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291.
Score: 0.036
-
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7420-7428.
Score: 0.034
-
The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2020 Feb; 27(2):352-358.
Score: 0.024
-
Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes. Ann Surg Oncol. 2015 Dec; 22(13):4295-304.
Score: 0.018
-
Utilization of radiotherapy for malignant phyllodes tumors: analysis of the National Cancer Data Base, 1998-2009. Ann Surg Oncol. 2014 Apr; 21(4):1222-30.
Score: 0.016
-
Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013 Dec; 20(13):4113-20.
Score: 0.016